Relationship between chronic obstructive pulmonary disease and levels of vitamin D

Year 2015, Volume: 42 Issue: 2, 158 - 165, 08.07.2015

Buket Çilingir , Hülya Günbatar

https://doi.org/10.5798/diclemedj.0921.2015.02.0551

Abstract

Objective: Vitamin D deficiency may be associated with pulmonary function deterioration. The aim of this study is to assess the relationship of serum vitamin D levels with pulmonary functions, disease severity and exacerbation frequency in Chronic Obstructive Pulmonary Disease (COPD) patients.

Methods: Seventy consecutive patients with COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II-IV) who presented to our outpatient clinic and thirdty controls entered to the study. Diagnosis of COPD was confirmed according to clinical findings and pulmonary function test. Serum 25-hydroxyvitamin D (25(OH)D levels were measured by immunofluorescence method. Levels <20 ng/mL defined deficiency. Associations between Vitamin D levels and sex, age, body mass index (BMI), smoking habit, comorbidities, exacerbation frequency were examined.

Results: The mean age of patients was 60.7 years. The proportion of patients in stages 2 of GOLD was 40 %, in stages 3 was 30 % and stages 4was 30 %. There was no significant difference in serum levels of 25(OH)D between COPD patients and controls. Vitamin D level was 9.3 ±6.0 ng/mL in control group and 9.7± 8.5 ng/mL in GOLD stage 2, 9.6 ± 6.2 ng/mL in stage 3 and 5.1 ±2.4 ng/mL in stage 4. In stage 4, vitamin D levels was significantly lower statistically (p=0.03). Among the COPD patients, lower FEV1 was associated with lower levels of 25(OH)D (p= 0.03). The most frequent comorbidities were hypertension (61.4%) and heart failure (27.1%). Among the COPD patients smoking associated with significantly lower levels of serum 25(OH) D (p=0.04). We find an association with exacerbation frequency in the previous 12 months and levels of 25(OH) D (p=0.02).

Conclusion: COPD severity according to GOLD stage is also associated with low levels of 25(OH)D. Serum vitamin D levels are lower in COPD patients who are current smokers. Severe vitamin D deficiency is related to more frequent disease exacerbations. These findings indicated a relationship between serum 25(OH)D concentrations and COPD which suggests optimization of serum vitamin D levels in COPD.

Key words: Pulmonary functions, Vitamin D, COPD

Keywords

Pulmonary functions, Vitamin D, COPD

Kronik obstruktif akciğer hastalığı ile vitamin D düzeyi arasındaki ilişki

Abstract

Amaç: Vitamin D eksikliği, solunum fonksiyonlarında bozulma ile ilişkili olabilir. Çalışmamızda Kronik Obstruktif Akciğer Hastalığı (KOAH) hastalarında solunum fonksiyonları, hastalığın şiddeti ve alevlenme sıklığı ile serum Vitamin D düzeyi arasındaki ilişkiyi belirlemeyi amaçladık. Yöntemler: Polikliniğimize başvuran 70 KOAH hastası (GOLD Sınıflaması Evre II-IV) çalışmaya alındı. 30 sağlıklı gönüllü kontrol grubunu oluşturdu. Klinik bulgular ve solunum fonksiyon testine göre KOAH tanısı kondu. Serum 25-hidroksi vitamin D (25(OH)D) seviyesi immünofloresan yöntemi ile ölçüldü. 20 ng/mL altındaki değerler eksiklik olarak kabul edildi. Vitamin D düzeyi ile cinsiyet, yaş, Vücut Kitle İndeksi (VKİ), sigara içme durumu, komorbiditeler, alevlenme sıklığı arasındaki ilişki araştırıldı.Bulgular: Hasta grubunun yaş ortalaması 60,7 yıldı. Hastaları GOLD sınıflamasına göre ayırdığımızda %40’ı Evre II, %30’u Evre III, %30’u Evre IV KOAH’tı. Hasta ve kontrol grupları arasında serum 25(OH)D düzeyi bakımından anlamlı farklılık görülmedi. Vitamin D düzeyi kontrol grubunda 9,3 ±6,0 ng/mL, Evre II KOAH’da 9,7± 8,5 ng/mL, Evre III’te 9,6 ± 6,2 ng/mL ve Evre IV’te 5,1 ±2,4 ng/mL olarak belirlendi. Evre IV te Vitamin D düzeyi düşüklüğü istatistiksel olarak anlamlıydı (p=0.03).Hasta grubunda düşük FEV1, düşük 25(OH)D ile ilişkili bulundu (p=0.03). En sık görülen komorbidite hipertansiyon (%61,4) ve kalp yetmezliği idi (%27,1). Sigara içenlerde 25(OH)D düzeyi daha düşüktü (p=0,004). Son 12 aydaki alevlenme sıklığı ile serum 25(OH)D düzeyi düşüklüğü arasında ilişki saptandı (p=0.02).Sonuç: GOLD evrelemesine göre KOAH şiddeti ile 25(OH)D düzeyi düşüklüğü arasında ilişki vardır. Sigara içen KOAH hastalarında 25(OH)D düzeyi daha düşüktür. Ciddi Vitamin D eksikliği alevlenme sıklığında artış ile ilişkilidir. 25(OH)D düzeyi ile KOAH arasındaki ilişki, KOAH hastalarında Vitamin D düzeyini iyileştirmek gerektiğini düşündürmektedir

Keywords

Solunum fonksiyonları, KOAH, Vitamin D

References

• Holick MF.Vitamin D deficiency. N Engl J Med 2007;
• :266-281.
• Cosio BG, Agusti A. Update in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 181:655-660.
• Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405-2411.
• Lemire JM, Adams JS, Kermani-Arab V, et al. 1,25-Dihy droxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134:3032-3035.
• Adams JS, Hewison M. Unexpected actions of vitamin D:
• new perspectives on the regulation of innate and adaptive
• immunity. Nat Clin Pract Endocrinol Metab 2008; 4:80-90.
• Hansdottir S, Monick MM, Hinde SL, et al. Respiratory
• epithelial cells convert inactive vitamin D to its active
• form: potential effects on host defense. J Immunol 2008;
• :7090-7099.
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA.
• Relationship between exacerbation frequency and lung
• function decline in chronic obstructive pulmonary disease.
• Thorax 2008; 57:847-852.
• Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 1998; 8:261-267.
• Dursun A. D vitamininin kemik metabolizması dışındaki
• etkileri. Beslenmede Yenilikler I-II, Katkı Pediatri Dergisi
• ; 28:225-234.
• Timms PM, Mannan N, Hitman GA, et al. Circulating
• MMP9, vitamin D and variation in the TIMP-1 response
• with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002; 95:787-796.
• Banerjee A, Panettieri RJr. Vitamin D modulates airway
• smooth muscle function in COPD. Curr opin Pharmacol 2012.
• Wright RJ. Make no nounes about it: epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005;128: 3871-3873.
• Sundar IK, Rahman I. Vitamin D and susceptibility of
• chronic lung disease: role of epigenetics. Front Pharmacol
• ; 2:50.
• Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D
• intake during pregnancy is inversely associated with asthma
• and allergic rhinitis. Clin Exp Allergy 2009; 39:875-882.
• Janssens W, Bouillon R, Claes B, et al. Vitamin D deficien
• cy is highly prevalent in COPD and correlates with variants
• in the vitamin D-binding gene. Thorax 2010; 65:215-220.
• Janssens W, Mathieu C, Boonen S, Decramer M. Vitamin
• D deficiency and chronic obstructive pulmonary disease: a
• vicious circle. Vitam Horm 2011; 86:379-99.
• Heulens N, Decramer M, Janssens W. Severe vitamin D
• deficiency: a biomarker of exacerbation risk? Am J Respir
• Crit Care Med. 2013; 187:214-215.
• Holick MF.Vitamin D deficiency. N Engl J Med 2007;
• :266-281.
• Murray CJ, Lopez AD. Alternative projections of mortalityand disability by cause 1990-2020: Global Burden of Disease Study.Lancet 1997; 349:1498-1504.
• Strassels SA, Smith DH, Sullivan SD, Mahajan PS.The
• costs of treating COPD in the United States. Chest
• ;119:344-352.
• Global Initiative for Chronic Obstructive Lung Disease.
• Global strategy for the diagnosis, management and prevention of COPD, 2015 (update) www.goldcopd.com.
• Norman AW, Bouillon R, Whiting SJ, et al. 13th Workshop
• consensus for vitamin D nutritional guidelines. J Steroid
• Biochem Mol Biol 2007; 103:204-205.
• Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates
• of optimal vitamin D status. Osteoporos Int 2005; 16:713-716.
• Alagöl F, Shihadeh Y, Boztepe H, et al. Sunlight exposure
• and vitamin D deficiency in Turkish Women. J Endocrinol
• Invest 2000; 23:173-177.
• Pehlivan İ, Hatun Ş, Aydoğan M, et al. Maternal serum vitamin D levels in the third trimester of pregnancy. Turk J Med
• Sci 2002; 32:237-241.
• Malabanan A, Veronikis IE, Holick MF.Redefining vitamin
• D insufficiency.Lancet 1998; 351:805-806.
• Vitamin D: extraskeletal health.Holick MF. Rheum Dis Clin
• North Am. 2012 Feb; 38:141-160.
• Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE. Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J 2011; 37:238-243.
• Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey.Chest 2005;
• :3792-3798.
• Ringbaek T, Martinez G, Durakovic A, et al. Vitamin D status in patients with chronic obstructive pulmonary disease who participate in pulmonary rehabilitation. J Cardiopulmonary Rehab Prevention 2011; 31:261-267.
• Franco CB, PazFillho G, Gomes PE, et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 2009;20:1881-1887.
• Persson LJP, Aanerud M, Hiemstra PS, et al. COPD is associated with low levels of vitamin D. PLoS One 2012;7:6.
• Celli BR, MacNee W. ATS/ERS Task Force. Standards for
• the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
• Semba RD, Chang SS, Sun K, et al.Serum 25-Hydroxyvitamin D and Pulmonary Function in Older Disabled Community-Dwelling Women. J Gerontol A Biol Sci Med Sci
• ; 67:683-689.
• Shaheen SO, Jameson KA, Robinson SM, et al.Relationship
• of vitamin D status to adult lung function and COPD. Thorax 2011; 66:692-698.
• Ampikaipakan SN, Hughes DA, Hughes JC, et al. Vitamin
• D and COPD: seasonal variation is important. Thorax 2011;
• :541-542.
• Jenkins CR, Celli B, Anderson JA, et al. Seasonality and
• determinants of moderate and severe COPD exacerbations
• in the TORCH study.Eur Respir J. 2012; 39:38-45.
• Lange NE, Sparrow D, Vokonas P, Litonjua AA.Vitamin
• D deficiency, Smoking, and Lung Function in the Normative Aging Study. Am J Respir Crit Care Med. 2012 Oct 1;186:616-621.
• Hughes DA, Norton R. Vitamin D and respiratory health.
• Clin Exp Immunol 2009; 158:20-25.
• Lee JH, O’Keefe JH, Bell D. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk
• factor? J Am Coll Cardiol 2008; 52:1949-1956.
• Forman JP, Williams JS, Fisher ND.Plasma 25-hydroxyvitamin D and regulation of the renin angiotensin system in humans. Hypertension 2010; 55:1283-1288.
• Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;
• :690-693.
• Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D
• and Diabetes. Diabetologia 2005; 48:1247-1257.
• McGill AT, Stewart JM, Lithander FE, et al. Relationships
• of low serum vitamin D3 with anthropometry and markers
• of the metabolic syndrome and diabetes in overweight and
• obesity. Nutr J 2008; 28:4-7.
• Agusti A, Soriano JB.COPD as a systemic disease. COPD
• ; 5:133-138.
• Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle
• crosssectional area is a better predictor of mortality than
• body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:809-813.
• Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza
• and vitamin D. Epidemiol Infect 2006;134: 1129-1140.
• Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge:
• ,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909-2912.
• Lehouck A, Mathieu C, Carremans C, et al. High doses of
• vitamin D to reduce exacerbations in chronic obstructive
• pulmonary disease: a randomized trial. Ann Intern Med
• ; 156:105-114.